Viewing StudyNCT03942094



Ignite Creation Date: 2024-05-06 @ 1:09 PM
Last Modification Date: 2024-10-26 @ 1:09 PM
Study NCT ID: NCT03942094
Status: UNKNOWN
Last Update Posted: 2022-03-16
First Post: 2019-05-06

Brief Title: Nilotinib for First-line Newly Diagnosed CML-CP Patients
Sponsor: Shenzhen Second Peoples Hospital
Organization: Shenzhen Second Peoples Hospital

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-06-01
Start Date Type: ACTUAL
Primary Completion Date: 2023-06-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-12-01
Completion Date Type: ESTIMATED
First Submit Date: 2019-05-06
First Submit QC Date: May 6 2019
Study First Post Date: 2019-05-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-03-15
Last Update Post Date: 2022-03-16
Last Update Post Date Type: ACTUAL